Equities

Strides Pharma Science Ltd

Strides Pharma Science Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)784.70
  • Today's Change9.60 / 1.24%
  • Shares traded181.34k
  • 1 Year change+176.30%
  • Beta1.1510
Data delayed at least 15 minutes, as of Mar 28 2024 10:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

  • Revenue in INR (TTM)39.53bn
  • Net income in INR-1.52bn
  • Incorporated1990
  • Employees2.85k
  • Location
    Strides Pharma Science LtdStrides HouseBannerghatta Road, BilekahalliBANGALORE 560076IndiaIND
  • Phone+91 8 067840000
  • Fax+91 8 067840700
  • Websitehttps://www.strides.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shilpa Medicare Ltd11.23bn-6.71m39.41bn1.03k----37.063.51-0.0714-0.0714131.44--------10,873,050.00--3.89--4.9264.4260.22-0.05389.29--1.16--10.65-8.335.82-153.54--14.58--
Aarti Pharmalabs Ltd18.32bn1.95bn39.46bn1.40k20.28--14.922.1521.4721.47202.17--------13,085,090.00--------42.00--10.62----16.14----62.11--58.27------
Advanced Enzyme Technologies Ltd6.05bn1.37bn39.65bn338.0028.87--22.846.5612.2812.2854.16--------17,892,400.00--11.87--13.1976.4272.2023.0225.79--59.04--7.492.136.44-11.663.2428.3214.87
Aarti Drugs Ltd26.51bn1.80bn40.52bn1.50k22.58--17.561.5319.5219.52287.30--------17,673,360.00--9.91--16.4032.2522.336.818.23--8.29--5.539.1416.56-18.8915.1117.2031.95
Orchid Pharma Ltd8.12bn1.25bn53.34bn838.0036.90--33.566.5728.5026.84175.33--------9,691,729.00---1.07---1.9641.4945.8715.63-3.52--4.34----19.00-0.6456187.87--68.72--
Blue Jet Healthcare Ltd-100.00bn-100.00bn64.97bn--------------------------------------------------5.49---11.88------
Marksans Pharma Ltd21.03bn3.17bn68.43bn1.40k21.42--17.683.257.057.0546.71--------15,024,090.00--14.78--19.5851.8850.1615.2113.01--44.45--5.4924.2315.2044.2951.896.6158.49
F D C Ltd19.16bn2.90bn69.02bn6.37k24.05--21.003.6017.6317.63116.59--------3,006,457.00--11.68--13.2965.7262.0315.1115.85--70.61--1.2216.7410.49-10.342.2625.03--
Strides Pharma Science Ltd39.53bn-1.52bn71.23bn2.85k----120.421.80-16.88-10.96436.72--------13,871,790.00---0.9448---1.5958.9049.75-4.37-2.19--0.9061----20.135.3351.93---25.10-5.59
Procter & Gamble Health Ltd12.37bn2.27bn78.66bn1.41k34.709.7631.166.36136.55136.55745.23485.491.152.5110.408,791,756.0021.02--27.67--69.97--18.32--2.79383.030.0132--10.34--19.19------
Wockhardt Ltd27.76bn-5.01bn80.39bn2.74k------2.90-34.79-34.79192.79--------10,131,390.00---4.12---7.3457.6053.98-19.16-10.98---0.1981-----17.93-7.60-129.10---7.43--
Neuland Laboratories Ltd.15.81bn3.17bn81.60bn1.57k25.73--21.835.16247.14247.141,232.07--------10,048,590.00--5.69--7.9551.7643.5620.068.07--28.54--8.2725.2517.62156.2168.43-13.12--
Jubilant Pharmova Ltd66.22bn378.60m90.60bn1.03k236.12--15.461.372.422.42415.43--------64,045,440.00--3.95--4.7867.6466.570.51336.27--1.36--18.522.47-3.63-114.73--10.7410.76
Glenmark Life Sciences Ltd23.68bn5.19bn94.41bn1.82k18.19--16.573.9942.3642.36193.15--------12,982,110.00--------55.92--21.93----538.47----1.79--11.52------
Caplin Point Laboratories Ltd16.30bn4.38bn95.92bn777.0022.03--19.595.8857.3357.33213.53--------20,980,180.00--21.04--24.2556.4852.8427.0825.02--845.56--9.3715.5422.1325.4921.0531.8717.61
Granules India Ltd45.26bn3.95bn104.23bn3.65k26.36--17.432.3016.3216.32186.88--------12,400,240.00--11.15--16.5551.9449.358.7312.39--6.53--10.0819.8421.6725.1631.26-1.668.45
Data as of Mar 28 2024. Currency figures normalised to Strides Pharma Science Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

30.48%Per cent of shares held by top holders
HolderShares% Held
Route One Investment Co. LPas of 31 Dec 20236.66m7.25%
quant Money Managers Ltd.as of 31 Dec 20234.98m5.42%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 15 Mar 20244.81m5.24%
Life Insurance Corporation of India (Investment Portfolio)as of 31 Dec 20233.81m4.15%
The Vanguard Group, Inc.as of 07 Mar 20242.38m2.59%
SBI Funds Management Ltd.as of 31 Dec 20231.96m2.14%
Dimensional Fund Advisors LPas of 07 Mar 20241.27m1.38%
BlackRock Fund Advisorsas of 07 Mar 20241.15m1.25%
Norges Bank Investment Managementas of 31 Dec 2023661.66k0.72%
SSgA Funds Management, Inc.as of 07 Mar 2024322.42k0.35%
More ▼
Data from 31 Dec 2023 - 20 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.